<DOC>
	<DOC>NCT01340937</DOC>
	<brief_summary>This study will determine whether three manufacturing lots of V419 (PR5I) induce similar immune responses to all of the antigens contained in V419 when given concomitantly with Prevnar13™ and RotaTeq™.</brief_summary>
	<brief_title>A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006)</brief_title>
	<detailed_description>This study is partially Double-Blinded in that the participants' parents/guardians, investigator/study site personnel, and Sponsor's representatives will be blinded to the lot of V419 the participant is randomized to receive, but not to the participant's treatment group (V419 or control).</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Inclusion Criteria : Participant is a healthy infant Participant has received one dose of monovalent hepatitis B vaccine prior to 1 month of age Exclusion Criteria : Participant has received more than one dose of monovalent hepatitis B vaccine or hepatitis B based combination vaccine prior to study entry Participant has been vaccinated with any acellular pertussis or whole cell pertussis based combination vaccines, haemophilus influenzae type b conjugate, poliovirus, pneumococcal conjugate or pneumococcal polysaccharide, rotavirus, measles, mumps, rubella, or varicella vaccines or any combination of the above Participant has had an illness with fever within 24 hours of study enrollment Participant was vaccinated with any nonstudy vaccine (i.e. inactivated, conjugated or live virus vaccine within 30 days prior to enrollment, except for inactivated influenza vaccine, which is permitted 15 days or more prior to enrollment Participant or his/her mother has hepatitis B surface antigen (HBsAg) seropositivity (by medical history) Participant has a history of haemophilus influenzae type B, hepatitis B, diphtheria, tetanus, pertussis, poliomyelitis, rotavirus, or pneumococcal infection</criteria>
	<gender>All</gender>
	<minimum_age>46 Days</minimum_age>
	<maximum_age>89 Days</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Diphtheria</keyword>
	<keyword>Tetanus</keyword>
	<keyword>Whooping Cough (pertussis)</keyword>
	<keyword>Poliomyelitis</keyword>
	<keyword>Hepatitis B infection</keyword>
	<keyword>Haemophilus influenzae type b infection</keyword>
</DOC>